Image not available in RecallScope.
Generic Name: MiniMed Go App Generic Name: MiniMed Go App Model Catalog Number: MMT-8600 (iOS), MMT-8601 (Android) Software Version
Official notice
28 Oct 2026
Last checked
2 Nov 2026
An official FDA notice concerns Generic Name: MiniMed Go App Generic Name: MiniMed Go App Model Catalog Number: MMT-8600 (iOS), MMT-8601 (Android) Software Version. A software defect in which existing users who had previously configured and enabled the long-acting dose reminder feature in version 1.2.0 or earlier experienced failure of the long-acting dose reminder after updating their app to version 1.2.1. The long-acting dose reminder is an optional feature that, when enabled, triggers a notification at the scheduled time to remind users to take their long-acting insulin dose. The issue was caused by a type cast exception during database migration that occurs upon app update to version 1.2.1 causing a silent failure that prevented the creation of new alerts. Failure to receive the long-acting dose reminder may result in missed or delayed insulin doses, potentially leading to hyperglycemia. Conversely, if users are uncertain whether they took their dose due to the missing reminder, inadvertent duplicate dosing may occur, potentially resulting in hypoglycemia. Published 2026-10-28.
What to do now
Stop using the affected device and follow the corrective action in the official FDA notice. Contact your healthcare provider or the manufacturer for next steps.
Units affected
623
Recall number
Z-0265-2027
Official notice
2026-10-28
The hazard
The hazard
A software defect in which existing users who had previously configured and enabled the long-acting dose reminder feature in version 1.2.0 or earlier experienced failure of the long-acting dose reminder after updating their app to version 1.2.1. The long-acting dose reminder is an optional feature that, when enabled, triggers a notification at the scheduled time to remind users to take their long-acting insulin dose. The issue was caused by a type cast exception during database migration that occurs upon app update to version 1.2.1 causing a silent failure that prevented the creation of new alerts. Failure to receive the long-acting dose reminder may result in missed or delayed insulin doses, potentially leading to hyperglycemia. Conversely, if users are uncertain whether they took their dose due to the missing reminder, inadvertent duplicate dosing may occur, potentially resulting in hypoglycemia.
How to check if you’re affected
How to check if you’re affected
Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.
Event Ids
Recall Numbers
Checked manually this time?
Follow brands and keywords in the app to receive alerts for matching official notices.
Turn on recall alertsAffected products
Affected products
Product 1
Units affected
Hazard
Where it was sold
Where it was sold
Retailer information is not currently available in RecallScope. Check the official notice for distribution details.
Location 1
Affected area 1
Affected area 2
Affected area 3
Affected area 4
Affected area 5
Affected area 6
Affected area 7
Affected area 8
Affected area 9
Affected area 10
Affected area 11
Affected area 12
Affected area 13
Company & contacts
Company & contacts
Brand: Medtronic Minimed. Contact: Medtronic MiniMed, Inc..
Source & status
Source & status
Recall details
Recall details
Recall number
Event ID
Units affected
Status
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeWeekly recall digest
Get next week’s recalls before you need them.
One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest arrives once a week. For matching recall alerts after notices are processed, get the app.